Search research articles
Contact Us
Filters
Showing results (101-110 of 159) with videos related to
Page
of 16
Sort By:
Trials
|
November 18, 2021
Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension
Amy Rogers, Angela Flynn, Isla S Mackenzie, et al.
BMC Cardiovascular Disorders
|
May 11, 2007
Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study
Hari K Parthasarathy, Khamis Alhashmi, Alex D McMahon, et al.
BMJ Open
|
September 10, 2016
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
Isla S Mackenzie, Ian Ford, Andrew Walker, et al.
BMJ Open
|
June 1, 2022
Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study
Amy Rogers, Evelien Rooke, Steve Morant, et al.
Journal of the American College of Cardiology
|
August 28, 2012
Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease
M Adnan Nadir, Sushma Rekhraj, Li Wei, et al.
American Heart Journal
|
September 20, 2005
Effects of eplerenone versus losartan in patients with low-renin hypertension
Myron H Weinberger, William B White, Luis-Miguel Ruilope, et al.
American Journal of Hypertension
|
October 21, 2020
Rationale and Design of the Genotype-Blinded Trial of Torasemide for the Treatment of Hypertension (BHF UMOD)
Linsay McCallum, Katriona Brooksbank, Alex McConnachie, et al.
Journal of Hypertension
|
July 4, 2019
Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension
Christopher R Gingles, Ruth Symon, Stephen J Gandy, et al.
Seminars in Arthritis and Rheumatism
|
February 25, 2014
Up-titration of allopurinol in patients with gout
Claudine G Jennings, Isla S Mackenzie, Rob Flynn, et al.
Pharmacoepidemiology and Drug Safety
|
December 5, 2002
The safety of drugs for OTC use: what evidence is required for an NSAID switch?
Thomas M MacDonald, Keith Beard, Rudolf Bruppacher, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 159) with videos related to
Sort By:
Page
of 16
Trials
|
November 18, 2021
Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension
Amy Rogers, Angela Flynn, Isla S Mackenzie, et al.
BMC Cardiovascular Disorders
|
May 11, 2007
Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study
Hari K Parthasarathy, Khamis Alhashmi, Alex D McMahon, et al.
BMJ Open
|
September 10, 2016
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
Isla S Mackenzie, Ian Ford, Andrew Walker, et al.
BMJ Open
|
June 1, 2022
Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study
Amy Rogers, Evelien Rooke, Steve Morant, et al.
Journal of the American College of Cardiology
|
August 28, 2012
Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease
M Adnan Nadir, Sushma Rekhraj, Li Wei, et al.
American Heart Journal
|
September 20, 2005
Effects of eplerenone versus losartan in patients with low-renin hypertension
Myron H Weinberger, William B White, Luis-Miguel Ruilope, et al.
American Journal of Hypertension
|
October 21, 2020
Rationale and Design of the Genotype-Blinded Trial of Torasemide for the Treatment of Hypertension (BHF UMOD)
Linsay McCallum, Katriona Brooksbank, Alex McConnachie, et al.
Journal of Hypertension
|
July 4, 2019
Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension
Christopher R Gingles, Ruth Symon, Stephen J Gandy, et al.
Seminars in Arthritis and Rheumatism
|
February 25, 2014
Up-titration of allopurinol in patients with gout
Claudine G Jennings, Isla S Mackenzie, Rob Flynn, et al.
Pharmacoepidemiology and Drug Safety
|
December 5, 2002
The safety of drugs for OTC use: what evidence is required for an NSAID switch?
Thomas M MacDonald, Keith Beard, Rudolf Bruppacher, et al.
Page
of 16